Delivery Order SPE2DB24D9313-SPE2DB24FFFGY

Award Date 7/9/24
Potential Completion Date 7/30/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,564,911,729 units of EXPAREL 266 MG/20 ML VIAL 20ML, a pain management medication, at a total ceiling value of $14,923.32. The delivery order is a firm fixed-price contract with a completion date of July 8, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery...
This is a $24,872.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML and has a completion date of May 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award...
This is a $27,359.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4565029494 - EXPAREL 266 MG/20 ML VIAL 20ML, with a period of performance through July 18, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,974.44 contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with an ultimate completion date of July 31, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,855.66 contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,928.66, is for the delivery of EXPAREL, a 266 mg/20 ml vial pharmaceutical product, with a performance period through March 9, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,923.32 contract is for the delivery of 4564084803 - EXPAREL 266 MG/20 ML VIAL 20ML, with a period of performance through April 15, 2024. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $10,270.50, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order was issued under a $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which runs through December 31, 2025. This...
This is a $29,846.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. The delivery order has an ultimate completion date of September 24, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,855.66, is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML medical product. The delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at up to $499,999,999 and running...
  • SPE2DB24D9313
    Indefinite Delivery Contract
  • SPE2DB24D9313-SPE2DB24FFFGY
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,427.82 order is for 133 mg/10 ml vials of the pain medication EXPAREL, with a completion date of July 30, 2024.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This order is part of that broader IDC vehicle. The contract has no set-aside designation.

Generated 10/8/24, 9:22 AM